Join Genomind’s Vice President of Medical Affairs, Dr. Daniel Dowd, for a clinical presentation. Dr. Dowd will discuss pharmacogenetic considerations that can be applied in the treatment of geriatric and comorbid patients. He will also demonstrate how Genomind’s precision gene-drug interaction software, can be utilized in the assessment of treatment options for this population.
Filmed June 17th, 2021
Are You Ready to Upgrade Your Practice with Genomind?
Genomind’s pharmacogenetic testing is the most advanced and comprehensive mental health pharmacogenetic test available. Get access to 24 genes related to mental health, 130+ medications, 10+ conditions, state-of-the-art tools, and 360 degrees of support. Register today.